BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/15/2021 8:09:29 AM | Browse: 908 | Download: 2433
Publication Name World Journal of Diabetes
Manuscript ID 67684
Country China
Received
2021-05-26 01:32
Peer-Review Started
2021-05-26 01:33
First Decision by Editorial Office Director
2021-06-16 14:28
Return for Revision
2021-06-16 14:28
Revised
2021-06-29 04:57
Publication Fee Transferred
Editorial Processing by Scientific Editor
2021-08-20 02:27
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director
2021-08-20 08:30
Articles in Press
2021-08-20 08:30
Edit the Manuscript by Language Editor
2021-09-05 09:29
Typeset the Manuscript
2021-11-03 04:33
Publish the Manuscript Online
2021-11-15 08:09
ISSN 1948-9358 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Endocrinology & Metabolism
Manuscript Type Basic Study
Article Title Profilin-1 is involved in macroangiopathy induced by advanced glycation end products via vascular remodeling and inflammation
Manuscript Source Unsolicited Manuscript
All Author List Zhi-Lin Xiao, Li-Ping Ma, Da-Feng Yang, Mei Yang, Zhen-Yu Li and Mei-Fang Chen
ORCID
Author(s) ORCID Number
Zhi-Lin Xiao http://orcid.org/0000-0003-4181-4935
Li-Ping Ma http://orcid.org/0000-0003-4904-0460
Da-Feng Yang http://orcid.org/0000-0002-8320-8215
Mei Yang http://orcid.org/0000-0002-4641-006X
Zhen-Yu Li http://orcid.org/0000-0002-1743-8610
Mei-Fang Chen http://orcid.org/0000-0002-3686-5933
Funding Agency and Grant Number
Funding Agency Grant Number
National Natural Science Foundation of China 81770358
National Natural Science Foundation of China 81000140
Natural Science Foundation of Hunan Province 2017JJ3486
the Fund for Health Care in Hunan Province B2017-01
National Natural Science Foundation of China 82000339
Corresponding Author Mei-Fang Chen, MD, PhD, Associate Professor, Department of Geriatric Cardiology, National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, No. 87 Xiangya Road, Kaifu District, Changsha 410008, Hunan Province, China. meifang121@sohu.com
Key Words Advanced glycation end products; Profilin-1; Diabetic macroangiopathy; Atherosclerosis; Vascular remodeling; Janus kinase 2/signal transducer and activator of transcription 3 signaling pathway
Core Tip The formation and accumulation of advanced glycation end products (AGEs) contributes to accelerated macrovascular complications in individuals with diabetes. Currently, few studies have examined the role of profilin-1 in vasculopathy induced by AGEs. The present study proved that AGEs induced proatherogenic events such as vascular smooth muscle cell proliferation, proatherogenic mediator expression and vascular remodeling, changes that were attenuated by silencing profilin-1 gene expression. These data suggested for the first time that profilin-1 was involved in AGEs-induced aortic atheroma formation in rats, indicating that drugs targeting profilin-1 may become a potential therapeutic strategy for ameliorating atherosclerosis secondary to diabetes.
Publish Date 2021-11-15 08:09
Citation Xiao ZL, Ma LP, Yang DF, Yang M, Li ZY, Chen MF. Profilin-1 is involved in macroangiopathy induced by advanced glycation end products via vascular remodeling and inflammation. World J Diabetes 2021; 12(11): 1875-1893
URL https://www.wjgnet.com/1948-9358/full/v12/i11/1875.htm
DOI https://dx.doi.org/10.4239/wjd.v12.i11.1875
Full Article (PDF) WJD-12-1875.pdf
Full Article (Word) WJD-12-1875.docx